Performance analysis of InMed Pharmaceuticals (INM)
Annual Return
Over the past 3 years, INM has had an average annual return of -59.02%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, INM has had an average annual return of -73.89%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, INM has had an average annual return of -47.10%, underperforming the benchmark SPY, which returned +15.44% annual.
Since May 5, 2014, INM has had an average annual return of -47.65%, underperforming the benchmark SPY, which returned +14.07% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +100% | -81.82% | -42.11% | -79.35% | -93.83% | -60.19% | -44.61% | -29.39% | -76.06% | +526.47% | +47.84% | -4.17% |
| 2014 | |||||||||||
| -54.89% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +50% | -33.33% | -50.00% | +100% | +100% | +0% | +100% | ||||||
| 2025 | -36.36% | +0% | -28.57% | +40% | -14.29% | +16.67% | -14.29% | -16.67% | +0% | -20.00% | -25.00% | -33.33% | -81.82% |
| 2024 | -15.79% | +18.75% | -10.53% | -29.41% | +8.33% | -7.69% | -33.33% | +100% | -31.25% | +9.09% | -16.67% | +10% | -42.11% |
| 2023 | -8.70% | -27.38% | -19.67% | +12.24% | +10.91% | -31.15% | +21.43% | -27.45% | -13.51% | -31.25% | -9.09% | -5.00% | -79.35% |
| 2022 | -7.64% | -22.13% | +0.09% | -3.45% | -15.43% | -38.88% | -17.16% | -38.96% | +10.70% | -53.67% | -12.95% | -23.97% | -93.83% |
| 2021 | +27.96% | +0.23% | -21.80% | +13.35% | -21.12% | +7.80% | -12.28% | -20.77% | -20.81% | -12.89% | +24.64% | -31.09% | -60.19% |
| 2020 | +49.99% | -5.18% | -39.45% | -2.57% | +57.60% | -21.43% | -36.64% | +7.68% | -19.91% | -1.02% | +8.47% | -9.12% | -44.61% |
| 2019 | +91.81% | -10.22% | -5.01% | -18.47% | -13.24% | -12.54% | -18.60% | +28.56% | -20.74% | -14.95% | +1.65% | -2.70% | -29.39% |
| 2018 | -10.89% | -26.87% | +55.04% | -20.82% | -8.10% | -26.56% | +3.30% | +6.06% | -1.59% | -33.87% | -4.64% | -34.80% | -76.06% |
| 2017 | +50.95% | +7.95% | +29.24% | +39.66% | -38.00% | -17.42% | +1.17% | -16.99% | +86.04% | -10.75% | +47.06% | +102.86% | +526.47% |
Drawdown analysis of InMed Pharmaceuticals (INM)
The maximum drawdown for the INM was -100.00%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current INM drawdown is -99.99%.
Since May 5, 2014 INM has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Jan 3, 2018 | 2068 | Mar 27, 2026 | Ongoing | Ongoing | Ongoing |
| -92.16% | Jun 20, 2014 | 519 | Jul 21, 2016 | 179 | Apr 6, 2017 | 698 |
| -68.21% | Apr 6, 2017 | 89 | Aug 14, 2017 | 82 | Dec 8, 2017 | 171 |
| -19.75% | Dec 11, 2017 | 6 | Dec 19, 2017 | 4 | Dec 26, 2017 | 10 |
| -17.07% | May 23, 2014 | 2 | May 28, 2014 | 5 | Jun 4, 2014 | 7 |
| -7.05% | Jun 18, 2014 | 1 | Jun 19, 2014 | 1 | Jun 20, 2014 | 2 |
| -4.72% | May 7, 2014 | 1 | May 8, 2014 | 10 | May 22, 2014 | 11 |
| -3.01% | May 5, 2014 | 1 | May 6, 2014 | 1 | May 7, 2014 | 2 |